Over the five years through 2022-23, dispensing chemist revenue is expected to dip at a compound annual rate of 2.2% to £11.5 billion. Revenue growth has come under intense pricing pressure due to regulatory amendments and the loss of patent protection. The government and industry bodies have fought to save dispensing chemists in light of these challenging conditions. Industry assistance initiatives include the Pharmacy Access Scheme, NHS Urgent Medicine Supply Advanced Service and the Quality Payment Schemes.Feeling unwell: Insufficient government funding and low incomes will take a hit on revenue in 2022-23
Companies in the industry dispense and sell pharmaceutical goods via community pharmacies and chemists. Pharmacies also provide other NHS services and sell over-the-counter medications and health-related products. This industry does not include non-health-related products, in-store supermarket pharmacies and online-only chemists.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Table of Contents
ABOUT THIS INDUSTRY
INDUSTRY PERFORMANCE
PRODUCTS & MARKETS
COMPETITIVE LANDSCAPE
OPERATING CONDITIONS
KEY STATISTICS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Lloyds Pharmacy Ltd
- Bestway (Holdings) Limited
- Boots UK Ltd
Methodology
LOADING...
